V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006704 | 300006988 | 1.56 | 55.55 | Curative (C) | 2017-12-05 | 2017-12-05 | Trial Unspecified | 02 | Y | 300019215 | CETUXIMAB + RT |
| 300006705 | 300006988 | 1.83 | 71 | Neo-adjuvant (N) | 2017-03-16 | 2017-04-10 | CAPECITABINE + GEMCITABINE | 02 | null | 300019215 | CAPECITABINE + GEMCITABINE |
| 300006706 | 300006988 | 1.64 | null | Neo-adjuvant (N) | 2013-10-19 | 2013-10-24 | Trial Unspecified | 02 | N | 300019215 | CARBOPLATIN + CETUXIMAB + FU |
| 300006707 | 300004790 | 1.6 | 55.6 | Curative (C) | 2013-04-18 | 2013-07-01 | Cetuximab 7 day (>Cycle 2) | 02 | Y | 300021064 | CARBOPLATIN |
| 300006708 | 300004791 | 1.8 | 54.3 | Curative (C) | 2013-09-10 | 2013-09-10 | CAPECITABINE + RT | N | Y | 300021511 | CAPECITABINE + OXALIPLATIN |
| 300006709 | 300004792 | 1.8 | 54.3 | null | 2015-09-28 | 2015-10-04 | CARBOPLATIN + PACLITAXEL | 2 | null | 300022240 | CETUXIMAB |
| 300006710 | 300004793 | 1.68 | 88.3 | Curative (C) | 2017-08-16 | 2017-08-30 | CARBOPLATIN + RT | N | Y | 300022247 | CISPLATIN |
| 300006711 | 300004794 | 1.8 | 101 | null | 2016-02-20 | 2016-02-20 | Trial Unspecified | 02 | null | 300022259 | CISPLATIN + FLUOROURACIL |
| 300006712 | 300006989 | 1.57 | 96.1 | Palliative (P) | 2016-12-06 | 2016-12-20 | CETUXIMAB | N | N | 300022287 | TEYSUNO |
| 300006715 | 300004797 | null | 84 | Not known (9) | null | 2016-11-30 | PACLITAXEL | null | N | 300022307 | CISPLATIN + FLUOROURACIL |
| 300006716 | 300006991 | null | 56 | null | 2016-03-21 | 2016-04-13 | CARBOPLATIN + RT | Y | Y | 300022313 | CETUXIMAB + RT |
| 300006719 | 300004801 | 1.79 | null | null | 2014-11-15 | 2014-11-27 | Cisplatin | 02 | Y | 300022324 | CETUXIMAB + RT |
| 300006720 | 300004802 | 1.85 | 68 | Palliative (P) | null | 2017-10-22 | Cisplatin 7 day | null | null | 300022333 | TRIAL |
| 300006721 | 300004803 | 1.61 | 0 | Palliative (P) | 2016-03-31 | 2016-05-05 | Carboplatin AUC 6 - 10 | N | null | 300022333 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006722 | 300004805 | null | 58.9 | Palliative (P) | 2015-09-11 | 2015-10-15 | Carboplatin+Fluorouracil 4 or 5 day | 02 | N | 300022345 | NAB-PACLITAXEL |
| 300006723 | 300004806 | null | 54.9 | Curative (C) | 2015-01-19 | 2015-01-26 | Cetuximab + Radiotherapy Maint | N | Y | 300022363 | CARBOPLATIN + RT |
| 300006724 | 300006994 | 1.63 | 82.1 | null | 2014-09-18 | 2014-09-18 | Irinotecan + Modified De Gramont | N | N | 300022371 | OXALIPLATIN + MDG |
| 300006726 | 300004808 | 1.6 | 50.9 | Palliative (P) | 2014-02-23 | 2014-02-23 | Trial Unspecified | 2 | Y | 300022394 | CARBOPLATIN |
| 300006727 | 300004808 | 1.62 | null | Neo-adjuvant (N) | 2018-08-31 | 2018-10-08 | Docetaxel | N | null | 300022394 | TRIAL |
| 300006728 | 300004808 | null | 70.85 | Adjuvant (A) | 2014-05-19 | 2014-05-28 | CAP + RT | null | Y | 300022394 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006729 | 300004809 | null | 71.8 | Palliative (P) | null | 2015-05-01 | CISPLATIN + FLUOROURACIL | null | null | 300022402 | CISPLATIN |
| 300006730 | 300004810 | 1.65 | 75 | Palliative (P) | 2015-06-25 | 2016-07-27 | CAPECITABINE + OXALIPLATIN | 02 | N | 300022410 | CISPLATIN |
| 300006731 | 300004811 | 1.62 | null | Neo-adjuvant (N) | 2017-11-13 | 2017-11-13 | CAPECITABINE + OXALIPLATIN | 2 | null | 300022410 | CETUXIMAB |
| 300006732 | 300004813 | 1.61 | null | Curative (C) | 2015-05-10 | 2015-06-13 | DE-ESCALATE TRIAL | null | null | 300022422 | CISPLATIN |
| 300006733 | 300004813 | 1.68 | null | Curative (C) | null | 2017-11-23 | Oxaliplatin + Modified de Gramont | Y | null | 300022422 | OXALIPLATIN |
| 300006734 | 300004814 | 1.77 | null | Palliative (P) | 2017-02-21 | 2017-02-24 | CISPLATIN + ETOPOSIDE | N | N | 300022428 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 300006735 | 300004816 | null | 62 | Neo-adjuvant (N) | null | 2016-11-18 | Sunitinib | 02 | N | 300022435 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006736 | 300004816 | null | null | Curative (C) | null | 2015-11-05 | CARBOPLATIN + Cetuximab + FLUOROURACIL | null | null | 300022435 | CAPECITABINE + GEMCITABINE |
| 300006737 | 300004817 | 1.56 | null | Palliative (P) | null | 2015-08-01 | CARBOPLATIN + RT | null | Y | 300022453 | CARBOPLATIN + RT |
| 300006738 | 300004818 | 1.77 | 70 | Palliative (P) | 2017-10-20 | 2017-10-20 | DE-ESCALATE TRIAL | N | null | 300022453 | CARBOPLATIN |
| 300006739 | 300004819 | null | 76.9 | null | 2017-09-07 | 2017-09-09 | Cetuximab + Radiotherapy Maint | N | Y | 300022468 | CISPLATIN |
| 300006741 | 300004822 | 1.49 | null | Curative (C) | 2014-07-20 | 2014-07-24 | Carboplatin + Paclitaxel (3 weekly) | null | null | 300022474 | TRIAL |
| 300006742 | 300007001 | 1.49 | 74.7 | Adjuvant (A) | 2014-12-14 | 2015-02-12 | Capecitabine | 02 | N | 300022483 | GEMCARBO |
| 300006743 | 300004824 | 1.79 | 72.8 | null | 2015-07-07 | 2015-07-25 | Capecitabine + Oxaliplatin 14day | 02 | N | 300022489 | BEVACIZUMAB + OXALIPLATIN + MdG |
| 300006744 | 300004825 | 1.83 | 84 | null | null | 2017-07-12 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 300022494 | CARBOPLATIN + PACLITAXEL |
| 300006745 | 300004826 | 1.7 | 87 | Neo-adjuvant (N) | 2016-02-29 | 2016-03-09 | Oxaliplatin + Modified de Gramont | N | N | 300022496 | CAPECITABINE + GEMCITABINE |
| 300006746 | 300004827 | 1.8 | 83.3 | Curative (C) | 2014-05-17 | 2014-05-19 | Capecitabine | 02 | N | 300022505 | CAPECITABINE |
| 300006747 | 300004829 | 1.6 | 112.5 | Neo-adjuvant (N) | null | 2018-04-02 | Folfirinox | N | null | 300022505 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006748 | 300004829 | 1.6 | 72.6 | null | 2015-02-15 | 2015-03-14 | CARBOPLATIN + RT | 02 | Y | 300022505 | CETUXIMAB + RT |
| 300006749 | 300004829 | 1.59 | 91 | Adjuvant (A) | 2015-12-11 | 2016-01-09 | CETUXIMAB + RT | N | Y | 300022505 | CAPECITABINE + RT |
| 300006750 | 300004829 | 1.68 | null | Palliative (P) | 2018-06-29 | 2018-07-31 | Carboplatin + Paclitaxel (weekly) | 02 | N | 300022505 | GEMCARBO |
| 300006751 | 300004829 | 1.45 | 74 | Neo-adjuvant (N) | 2017-06-17 | 2017-07-01 | Trial Unspecified | N | N | 300022505 | CAPECITABINE + OXALIPLATIN |
| 300006752 | 300004831 | 1.66 | 54.7 | Neo-adjuvant (N) | 2014-04-30 | 2014-07-19 | Cisplatin + Docetaxel | 2 | null | 300022551 | ESPAC TRIAL |
| 300006753 | 300004831 | 1.89 | 66.2 | Neo-adjuvant (N) | 2016-08-10 | 2016-08-10 | CHOP R + LIPOSOMAL DOX | null | null | 300022551 | CAPECITABINE |
| 300006754 | 300004831 | 1.55 | 46.6 | Neo-adjuvant (N) | 2015-01-05 | 2015-01-06 | Cisplatin + Fluorouracil + RT 5day | 02 | Y | 300022551 | CISPLATIN |
| 300006758 | 300004836 | null | null | Palliative (P) | 2013-03-08 | 2013-03-08 | Carboplatin + Cetux + FU (Cycle 1) | 02 | N | 300022617 | CISPLATIN |
| 300006759 | 300004837 | 1.78 | 86.4 | Palliative (P) | null | 2014-07-31 | NIVOLUMAB | N | N | 300022620 | TRIAL |
| 300006760 | 300004837 | 1.86 | null | Palliative (P) | 2018-05-18 | 2018-05-20 | FLUOROURACIL + OXALIPLATIN | 02 | N | 300022620 | OXALIPLATIN + MDG |
| 300006761 | 300004838 | 1.65 | 68.1 | Palliative (P) | 2017-09-02 | 2017-09-10 | Carboplatin + Etoposide IV 3 day | N | N | 300022645 | CAPECITABINE |
| 300006762 | 300004840 | 1.55 | null | Curative (C) | 2013-04-07 | 2013-05-03 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 300022646 | DE-ESCALATE TRIAL |